SEC Filings
J&J's Talc Reserve Is Now About $9.0 Billion, And The Ovarian Deal Hinges On 95% Of Claims
J&J's 10-Q puts the talc reserve at about $9.0 billion, with cash lower and Sail, bond and opioid bills also due.
Johnson & Johnson (JNJ) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
SEC Filings
J&J's 10-Q puts the talc reserve at about $9.0 billion, with cash lower and Sail, bond and opioid bills also due.
Earnings
The finance chief favored a spin-off of the orthopedics unit as MedTech sales rose 2.5%, a result its chief said missed J&J's own standard.
Earnings
Third-quarter sales rose 5.9% to $25.4 billion, and the company lifted its full-year adjusted earnings-per-share forecast by $0.06.